MRA in HFrEF RALES 1999 ⬇️ ☠️ HR 0.70 (0.60-0.83) p<0.001 EMPHASIS-HF 2010 ⬇️ ☠️ HR 0.76 (0.62-0.93) p=0.008 Class 1 in guidelines for HFrEF Cost of Rx ~$40 per year Use in routine US clinical practice in eligible patients without CI/intolerance in 2024? <40% 🚨🚨🚨🚨🚨

Thanks to Husam Abdel-Qadir for presenting our work on Disparities in diabetes-related outcomes in prostate cancer patients - role of social determinants of health and race. Priyanshu nain - DM increases all type of cv events and mortality in PC especially in those with disparity.

Happy Labor Day! Many are celebrating with a 4-day week, but this school of pharmacy has this all year. Lea S Eiland Taylor Steuber #PharmEd #wellbeing sciencedirect.com/science/articl…

So exciting, another OTC CGM option from Abbott. Now we have Lingo (abbott) and Stelo (Dexcom)

Five years ago I had suicidal ideation due to repeated sleep deprivation. I was a resident working long hours, including 28-hour calls. Sleep deprivation is an independent risk factor for suicide. Any discussion about physician wellness is wholly inadequate if it excludes sleep.

The only way to take the sorrow out of death is to take the love out of life

Also me when my husband asks where I’m going to display and store the 100th pumpkin pillow I’m eyeing at the store.

If you can’t Then you don’t handle me deserve me at my at my

Bet you didn’t have amb care and crit care collaborating on research on your 2024 BINGO card!

New study shows near-peer teaching in pharmacy skills labs increased P3 students' confidence in giving feedback (67-68%) and improved P1 students' communication with patients and providers (73-80%). #TwitteRx #PharmEd

A young doctor’s final words offer a mental health warning for others Will West, a 33-year-old who was training at George Washington University hospital in D.C., wrote in a suicide note that other residents are “at real risk” washingtonpost.com/dc-md-va/2024/… #InsideTheMatch

Our students give so much to the community. Please spread the word and consider donating to support them as they continue their studies amongst the damage. ❤️💊

SOUL top line N=9560 T2D + CVD or CKD Oral semaglutide 14% ⬇️ in MACE As part of standard of care, 49% of patients received SGLT2i at some point during the trial novonordisk.com/content/nncorp…

📢👋We are excited to announce that we are recruiting for our inaugural PGY2 Ambulatory Care Resident to start in July 2025! ☑️Follow us to stay up to date! We will be showcasing recruitment events, preceptor highlights and more!! #Twitterx #pharmacist #Cometothebay #GoBulls

New NEJM A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of >2,500 participants with obesity, absolute reduction of 10/100 treated nejm.org/doi/full/10.10… by Ania M. Jastreboff, MD, PhD and

Mark your calendars! 📅 We will be at the ASHP Midyear Meeting recruiting for our #PGY2 in #AmbulatoryCare

Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity: NEJM 🥸The SUMMIT trial - AHA Science 😱 Summary 👇👇👇

Meet Raechel White in our first preceptor shoutout!

Our #AHA24 presence from #cardioonc program at Georgia Cancer Center MCG on Thread Reader App threadreaderapp.com/thread/1857894… Overall theme and take homes Health disparities in cardiovascular disease (CVD) remain significant across the board. In cardio-oncology, especially with

Takeaways from #AHA2024. Late breaking trials - take home points AHA Science   1. BPROAD Trial: Intensive treatment targeting SBP ≤120 mmHg reduced the incidence of MACE at 5 years vs. standard treatment targeting ≤140 mmHg in patients with type 2 diabetes and hypertension with